Kara M. Schenk

429 total citations
11 papers, 262 citations indexed

About

Kara M. Schenk is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Kara M. Schenk has authored 11 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Kara M. Schenk's work include Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers) and Respiratory viral infections research (1 paper). Kara M. Schenk is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers) and Respiratory viral infections research (1 paper). Kara M. Schenk collaborates with scholars based in United States, Germany and Türkiye. Kara M. Schenk's co-authors include Thomas O. Crawford, Marlene R. Miller, Michael L. Rinke, David G. Bundy, Aaron M. Milstone, Cory Brayton, Byunghak Kang, Valeriya Gaysinskaya, Elizabeth Pugh and Murat O. Arcasoy and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Critical Care Medicine.

In The Last Decade

Kara M. Schenk

11 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kara M. Schenk United States 7 107 50 50 45 38 11 262
Filippo Andò Italy 8 48 0.4× 151 3.0× 37 0.7× 20 0.4× 41 1.1× 20 403
Justin Garner United Kingdom 10 50 0.5× 64 1.3× 13 0.3× 7 0.2× 14 0.4× 35 335
Mark Bieniarz United States 7 143 1.3× 11 0.2× 27 0.5× 21 0.5× 24 0.6× 9 399
Valentina Talarico Italy 10 63 0.6× 17 0.3× 32 0.6× 14 0.3× 32 0.8× 32 308
Gi Soo Lee United States 8 31 0.3× 66 1.3× 5 0.1× 21 0.5× 14 0.4× 21 252
Amy S. Tsai United States 11 47 0.4× 10 0.2× 7 0.1× 9 0.2× 52 1.4× 15 262
Virginia Mirra Italy 11 51 0.5× 77 1.5× 23 0.5× 4 0.1× 38 1.0× 18 391
Peter A. Nagi United States 5 84 0.8× 24 0.5× 3 0.1× 65 1.4× 10 0.3× 8 302
Pramod Kumar India 11 48 0.4× 41 0.8× 3 0.1× 38 0.8× 36 0.9× 33 277

Countries citing papers authored by Kara M. Schenk

Since Specialization
Citations

This map shows the geographic impact of Kara M. Schenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara M. Schenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara M. Schenk more than expected).

Fields of papers citing papers by Kara M. Schenk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara M. Schenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara M. Schenk. The network helps show where Kara M. Schenk may publish in the future.

Co-authorship network of co-authors of Kara M. Schenk

This figure shows the co-authorship network connecting the top 25 collaborators of Kara M. Schenk. A scholar is included among the top collaborators of Kara M. Schenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara M. Schenk. Kara M. Schenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Deutsch, Julie S., Jonathan R. Lai, Kara M. Schenk, et al.. (2023). Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade. Journal for ImmunoTherapy of Cancer. 11(12). e007463–e007463. 6 indexed citations
2.
Schenk, Kara M., Megan D. Schollenberger, William H. Sharfman, et al.. (2022). 820P Nivolumab (NIVO) +/- relatlimab (RELA) or ipilimumab (IPI) for patients (pts) with advanced treatment-naïve or -refractory basal cell carcinoma (BCC). Annals of Oncology. 33. S922–S923. 6 indexed citations
3.
Schenk, Kara M., Julie E. Stein, Sunandana Chandra, et al.. (2022). Nivolumab (NIVO) + tacrolimus (TACRO) + prednisone (PRED) +/- ipilimumab (IPI) for kidney transplant recipients (KTR) with advanced cutaneous cancers.. Journal of Clinical Oncology. 40(16_suppl). 9507–9507. 14 indexed citations
4.
Giraldo, Nicolás A., Sneha Berry, Étienne Becht, et al.. (2021). Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery. Cancer Immunology Research. 9(11). 1262–1269. 6 indexed citations
5.
Gable, Dustin L., Valeriya Gaysinskaya, C. Conover Talbot, et al.. (2019). ZCCHC8, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation. Genes & Development. 33(19-20). 1381–1396. 79 indexed citations
6.
Schenk, Kara M., Joshua E. Reuss, Karin Choquette, & Alexander I. Spira. (2019). A review of canakinumab and its therapeutic potential for non-small cell lung cancer. Anti-Cancer Drugs. 30(9). 879–885. 17 indexed citations
7.
Schenk, Kara M., Michael L. Rinke, David G. Bundy, et al.. (2019). Pediatric Hospitalizations: Are We Missing an Opportunity to Immunize?. Hospital Pediatrics. 9(9). 673–680. 6 indexed citations
8.
Schenk, Kara M. & Thomas O. Crawford. (2014). Motor and Cognitive Delay in Duchenne Muscular Dystrophy: Implication for Early Diagnosis. The Journal of Pediatrics. 165(5). 1008–1010. 46 indexed citations
9.
Rinke, Michael L., Aaron M. Milstone, Allen Chen, et al.. (2013). Ambulatory pediatric oncology CLABSIs: Epidemiology and risk factors. Pediatric Blood & Cancer. 60(11). 1882–1889. 54 indexed citations
10.
Mirski, Marek A., et al.. (2010). Validity and reliability of an intuitive conscious sedation scoring tool: The nursing instrument for the communication of sedation*. Critical Care Medicine. 38(8). 1674–1684. 25 indexed citations
11.
Schenk, Kara M., et al.. (1989). Mutation induction in haploid yeast after split-dose radiation-exposure. Radiation and Environmental Biophysics. 28(2). 101–111. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026